Comparing Saphris vs Vraylar
Saphris | Vraylar |
|
---|
Saphris (asenapine) | Vraylar (cariprazine) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Bipolar Disorder, Schizophrenia. Saphris may also be used for purposes not listed in this medication guide. |
Prescription only
Vraylar is an atypical antipsychotic that is effective for the treatment of schizophrenia and bipolar disorder. Vraylar is usually well-tolerated and less likely than some other antipsychotics to... View more |
Related suggestions Schizophrenia
Popular comparisons
|
|||||||||||||||
More about Saphris (asenapine) | More about Vraylar (cariprazine) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Saphris has an average rating of 7.4 out of 10 from a total of 315 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 18% reported a negative effect. |
Vraylar has an average rating of 5.8 out of 10 from a total of 474 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: Saphris side effects in more detail. |
See also: Vraylar side effects in more detail. |
||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Saphris prices |
View all Vraylar prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other asenapine brands include: Secuado |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
24 hours |
504 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 641 drugs are known to interact with Saphris:
|
A total of 561 drugs are known to interact with Vraylar:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
August 13, 2009 |
September 17, 2015 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.